Strategic Planning and Situation Assessment for Cervical Cancer Prevention: Practical Experience from PATH
From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) vaccines. This is part of a series of reports that summarizes lessons learned from these projects to help guide future HPV vaccination program planning, especially in low-resource settings. This report is intended to help decision-makers and program planners focus on key “big picture” questions about cervical cancer prioritization and on opportunities and challenges for improved cancer prevention, including vaccination of girls and precancer screening and treatment of adult women.
» Download file (English)
1.41 MB PDF (Located at www.path.org)
» Download file (French)
769 KB PDF (Located at www.path.org)
Also known as: Planification stratégique et évaluation de situation pour la prévention du cancer du col utérin: Expérience pratique de PATH
Diseases/vaccines: Human papillomavirus (HPV)